Methods of treating dry eye disorders

Details Methods of treating dry eye disorders Methods of treating dry eye disorders

2006-04-11

2006-04-11

Tate, Christopher R. (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

Reexamination Certificate

active

07026296

ABSTRACT:
Inhibitors of cytokine synthesis in nonimmune, resident ocular surface cells are useful for treating dry eye disorders and other disorders requiring the wetting of the eye.

REFERENCES:
patent: 4131651 (1978-12-01), Shah et al.
patent: 4370325 (1983-01-01), Packman
patent: 4409205 (1983-10-01), Shively
patent: 4744980 (1988-05-01), Holly
patent: 4753945 (1988-06-01), Gilbard et al.
patent: 4818537 (1989-04-01), Guo
patent: 4883658 (1989-11-01), Holly
patent: 4914088 (1990-04-01), Glonek et al.
patent: 4966773 (1990-10-01), Gressel et al.
patent: 5041434 (1991-08-01), Lubkin
patent: 5075104 (1991-12-01), Gressel et al.
patent: 5174988 (1992-12-01), Mautone et al.
patent: 5278151 (1994-01-01), Korb et al.
patent: 5290572 (1994-03-01), MacKeen
patent: 5294607 (1994-03-01), Glonek et al.
patent: 5371108 (1994-12-01), Korb et al.
patent: 5578586 (1996-11-01), Glonek et al.
patent: 5696166 (1997-12-01), Yanni et al.
patent: 5712298 (1998-01-01), Amschler
patent: 5800807 (1998-09-01), Hu et al.
patent: 5980929 (1999-11-01), de Juan, Jr.
patent: 6083903 (2000-07-01), Adams et al.
patent: 6153607 (2000-11-01), Pflugfelder et al.
patent: 6255343 (2001-07-01), Belanger
patent: 6320062 (2001-11-01), Belanger
patent: 6326499 (2001-12-01), Belanger
patent: 6331566 (2001-12-01), Conrow et al.
patent: 6331644 (2001-12-01), Klimko et al.
patent: 6342525 (2002-01-01), Klimko et al.
patent: 6353012 (2002-03-01), Hellberg et al.
patent: 6353022 (2002-03-01), Schneider et al.
patent: 6353032 (2002-03-01), Graff et al.
patent: 6399322 (2002-06-01), Glimcher et al.
patent: 6429227 (2002-08-01), Schneider et al.
patent: 6458853 (2002-10-01), Graff et al.
patent: 6458854 (2002-10-01), Graff et al.
patent: 6552084 (2003-04-01), Klimko et al.
patent: 6696453 (2004-02-01), Gamache et al.
patent: 2001/0031260 (2001-10-01), Lee et al.
patent: 2002/0151491 (2002-10-01), Li et al.
patent: 2004/0235864 (2004-11-01), Graczyk et al.
patent: 1 082 962 (2001-03-01), None
patent: 10036289 (1998-02-01), None
patent: 10330257 (1998-12-01), None
patent: WO 95/01338 (1995-01-01), None
patent: WO 00/03705 (2000-01-01), None
patent: WO 00/26209 (2000-05-01), None
patent: WO 02/13812 (2002-02-01), None
patent: WO 02/13812 (2002-02-01), None
patent: WO 02/056888 (2002-07-01), None
patent: WO 02/095704 (2002-11-01), None
patent: WO 03/045225 (2003-06-01), None
patent: WO 03/099278 (2003-12-01), None
patent: WO 03/099334 (2003-12-01), None
Bennett et al., “SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase,”Proceedings of the National Academy of Sciences of the United States, vol. 98(24); pp. 13681-13686 (2001.
Goldman et al., “SP100030 is a Novel T-Cell-Specific Transcription factor Inhibitor that Possesses Immunosuppressive Activity In Vivo,”Transplantation Proceedings, vol. 28(6);, pp. 3106-3109 (1996).
Jackson et al., “Pharmacological Effects of SP 220025, a Selective Inhibitor of P38 Mitogen-Activated protein Kinase, in Angiogenesis and Chronic Inflammatory Disease Models,”J. of Pharmacology and Experimental Therapeutics, vol. 284(2), pp. 687-692 (1998).
Pflugfelder et al., “The Diagnosis and Management of Dry Eye,”Cornea, vol. 19(5), pp. 644-649 (2000).
Stern et al., “The Pathology of Dry Eye: The Interaction Between the Ocular Survace and Lacrimal Glands,”Cornea, vol. 17(6), pp. 584-589 (1998).
Lemp et al., “Report of the National Eye Institute/Industry Workshop on Clinical Trials in Dry Eyes,”CLAO, vol. 21(4), pp. 221-231 (1995).
McCulley et al., “Tear Film Structure and Dry Eye,”Contactologia, vol. 20, pp. 145-149 (1998).
Marsh et al., “Topical Nonpreserved Methylprednisolone Therapy for Keratoconjunctivitis Sicca in Sjogren Syndrome,” Opthalmology, vol. 106(4), pp. 811-816 (1999).
Pisella et al., “Flow Cytometric Analysis of Conjunctival Epithelium in Ocular Rosacea and Keratoconjunctivitis Sicca,” Ophthalmology, vol. 107(10), pp. 1841-1849 (2000).
Shine et al., “Keratoconjunctivitis Sicca Associated with Meibomian Secretion Polar Lipid Abnormality,” Arch. Ophthalmol. vol. 116, pp. 849-852 (1998).
Tauber et al., “A Dose-Ranging Clinical Trial to Assess the Safety and Efficacy of Cyclosporine Ophthalmic Emulsion in Patients with Keratoconjunctivitis Sicca,” Lacrimal Gland, Tear Film and Dry Eye Syndromes 2, edited by Sullivan et al., Plenum Press, New York, pp. 969-972 (1998).
Abelson et al., “Loteprednol Etabonate in the Management of Dry Eye Inflammation,” Supplement toRefractive Eyecare® for Ophthalmologists, pp. 1-15 (Nov., 2000).

Affiliated with

Also associated with

Rating

Methods of treating dry eye disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of treating dry eye disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating dry eye disorders will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3558157